Evidence map›Paper›PMID 17687264›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2008

Dopamine depletion of the prefrontal cortex induces dendritic spine loss: reversal by atypical antipsychotic drug treatment.

Hui-Dong Wang, Ariel Y Deutch

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 2 pooled it
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 2 syntheses or guidelines pooled it, 81 citations in OpenAlex.

  1. Pooled it
  2. Antioxidant treatments for schizophrenia.The Cochrane database of systematic reviews · 2016
    Pooled it
  3. Modulation of limbic circuitry predicts treatment response to antipsychotic medication: a functional imaging study in schizophrenia.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2009
    Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Levodopa treatment and dendritic spine pathology.Movement disorders : official journal of the Movement Disorder Society · 2018
    Review
  14. Dopamine Synthesis Capacity is Associated with D2/3 Receptor Binding but Not Dopamine Release.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Article
  15. Article
  16. Article
  17. Dopaminergic control of anxiety in young and aged zebrafish.Pharmacology, biochemistry, and behavior · 2017
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Hui-Dong WangDepartment of Psychiatry, Vanderbilt University Medical Center, Nashville, TN 37212, USA. huidong.wang@vanderbilt.edu
Ariel Y Deutch
Vanderbilt University Medical Center · US

Funding

Regulation of striatal plasticity by phosphatasesP01NS044282 · NINDS · VANDERBILT UNIVERSITY · PI DEUTCH, ARIEL Y · 2002 to 2006
$5.0M
Dopaminergic Regulation of Pyramidal CellsR01MH077298 · NIMH · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DEUTCH, ARIEL Y · 2007 to 2016
$3.6M
NIMH NIH HHS R01 MH077298NINDS NIH HHS P01 NS044282
6 · The paper itself

Abstract

Dystrophic changes in dendrites of cortical neurons are present in several neuro-psychiatric disorders, including schizophrenia. The mechanisms that account for dendritic changes in the prefrontal cortex (PFC) in schizophrenia are unclear. Cognitive deficits in schizophrenia have been linked to compromised cortical dopamine function, and the density of the PFC dopamine innervation is decreased in schizophrenia. We determined if 6-hydroxydopamine lesions of the ventral tegmental area that disrupt the PFC dopamine innervation cause dystrophic changes in cortical neurons. Three weeks post-operatively we observed a marked decrease in basal dendritic length and spine density of layer V pyramidal cells in the prelimbic cortex; no change was seen in neurons of the motor cortex. We then examined rats in which the PFC dopamine innervation was lesioned and 3 weeks later were started on chronic treatment with an atypical (olanzapine) or typical (haloperidol) antipsychotic drug. Olanzapine but not haloperidol reversed lesion-induced changes in PFC pyramidal cell dendrites. These data suggest that dopamine regulates dendritic structure in PFC neurons. Moreover, the findings are consistent with a decrease in cortical dopaminergic tone contributing to the pathological changes in the cortex of schizophrenia, and suggest that the progressive cortical loss in schizophrenia may be slowed or reversed by treatment with atypical antipsychotic drugs.

Indexed as

Prefrontal CortexAdrenergic AgentsAnalysis of VarianceAnimalsAntipsychotic AgentsBehavior, AnimalBenzodiazepinesDendritic SpinesDopamineHaloperidolMaleNeuronsOlanzapineOxidopamineRatsRats, Sprague-DawleyAdrenergic AgentsAntipsychotic AgentsBenzodiazepinesDopamineHaloperidolOlanzapineOxidopamine

Identifiers

PMID17687264
PMCPMC4753804
OpenAlexW2061407859

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.